CLINICAL_TRIALS trial_result · 2016-10-27

Clinical Trial Update: A Pharmacokinetic Substudy of the TDE-PH-304 Protocol [Phase 3]

A pharmacokinetic substudy embedded in a Phase 3 trial of TDE-PH-304 in pulmonary arterial hypertension has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: United Therapeutics | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2016-10-27